Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Gascun
C
C
Rajan
L
L
O'Neill
E
E
Smyth
E G
EG
D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance / Q000187:drug effects*; D008875:Middle Aged; D023303:Oxazolidinones / Q000008:administration & dosage / Q000627:therapeutic use*; D018805:Sepsis / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid